The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Bronxville, NY

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Charles Drake is an Internal Medicine provider in New York, New York. Dr. Drake is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Prostatectomy.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Michael Stifelman is a Urologist in Hackensack, New Jersey. Dr. Stifelman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction.

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Dr. Weber graduated from the Albert Einstein College of Medicine and finished her residency in Radiology at the Long Island Jewish/North Shore University Hospital, where she served as Chief Resident. She received fellowship training in Breast and Body Imaging at the Mount Sinai School of Medicine in New York, and she is board-certified in Radiology. Dr. Weber is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Chronic Cough, Non-Alcoholic Fatty Liver Disease, Visceromegaly, and Emphysema.

Stephen W. Reese, MD, is an attending physician at Montefiore Einstein and Assistant Professor at our Albert Einstein College of Medicine. Dr. Reese cares for patients with urologic cancers, using minimally invasive and open surgical approaches. He has a particular interest in the management of urologic cancers, including kidney, prostate, bladder, adrenal and testicular cancer and works to care for patients in a multidisciplinary setting with his colleagues in medical and radiation oncology. In 2017, Dr. Reese received his Doctor of Medicine at Boston University School of Medicine. He completed his residency training at Brigham and Women’s Hospital in Boston, MA in 2022 and then completed a Society of Urologic Oncology (SUO) Fellowship at Memorial Sloan Kettering Cancer Center in 2024. Dr. Reese is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Venous Thromboembolism (VTE), Renal Oncocytoma, Nephrectomy, and Cystectomy.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.

Dr. Dwight Aberle is an assistant professor of radiology at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and an attending radiologist at NewYork-Presbyterian Hospital. Dr. Aberle earned his medical degree at NYU Grossman School of Medicine and completed a diagnostic radiology residency at NewYork-Presbyterian/CUIMC, where he served as chief resident. He then went on to complete an Abdominal Imaging Fellowship with the Department of Radiology at VP&S before joining our faculty. Dr. Aberle is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Pleural Effusion, Pleurisy, Cholangiocarcinoma (Bile Duct Cancer), and Non-Muscle Invasive Bladder Cancer.

Marc Janis is a Urologist in Mount Vernon, New York. Dr. Janis is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

Thomas Rechtschaffen is a Urologist in Yonkers, New York. Dr. Rechtschaffen is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Interstitial Cystitis, Enlarged Prostate (BPH), UPJ Obstruction, Ureteroscopy, and Prostatectomy.

Alexander C. Small, MD, is an Attending Physician and Assistant Professor at Montefiore-Einstein. Dr. Small specializes in the treatment of urological diseases, cancer and kidney stones through the use of minimally invasive, robotic and endoscopic surgery. Dr. Small is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy.

David Loeb, MD, PhD, is Chief, Pediatric Hematology, Oncology and Cellular Therapy at Children’s Hospital at Montefiore and Professor, Pediatrics and Professor, Developmental and Molecular Biology at Montefiore Einstein. His clinical work focuses on tumors of connective tissue, such as bone and muscle. He also has expertise in the care of children with other solid tumors. As a member of the bone marrow transplantation team, Dr. Loeb also cares for patients with acute leukemias and has expertise in the application of immunotherapy to childhood cancer. Dr. Loeb is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Bone Tumor.

Robert Berkenblit, MD, FACR, is Associate Medical Director at the Montefiore Imaging Center and Associate Professor of Radiology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 1996, his clinical interests include utilizing CT scans, ultrasound, and MRIs to evaluate the abdomen and pelvis, particularly the genitourinary system and the adrenal glands. He also has a special interest in utilizing an open MRI system to evaluate the abdomen and pelvis. Dr. Berkenblit is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Visceromegaly, WT1-Related Wilms Tumor Syndromes, Chronic Cough, and Ureterocele.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Ketan Badani is a Urologist in New York, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Reza Mehrazin is a Urologist in New York, New York. Dr. Mehrazin is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Mehrazin is currently accepting new patients.

John Sfakianos is a Urologist in Astoria, New York. Dr. Sfakianos is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.

Cora Sternberg is an Oncologist in New York, New York. Dr. Sternberg is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Sternberg is currently accepting new patients.